| [1] |
Widuchowski W, Widuchowski J, Trzaska T. Articular cartilage defects: study of 25，124 knee arthroscopies[J]. Knee, 2007, 14(3): 177-82.
|
| [2] |
Arøen A, Løken S, Heir S, et al. Articular cartilage lesions in 993 consecutive knee arthroscopies[J]. Am J Sports Med, 2004, 32(1): 211-215.
|
| [3] |
Heir S, Nerhus TK, Røtterud JH, et al. Focal cartilage defects in the knee impair quality of life as much as severe osteoarthritis: a comparison of knee injury and osteoarthritis outcome score in 4 patient categories scheduled for knee surgery[J]. Am J Sports Med, 2010, 38(2): 231-237.
|
| [4] |
Davies RL, Kuiper NJ. Regenerative Medicine: a review of the evolution of autologous chondrocyte Implantation (ACI) therapy[J/OL]. Bioengineering (Basel), 2019, 6(1). DOI： 10.3390/bioengineering6010022.
|
| [5] |
Lee WY, Wang B. Cartilage repair by mesenchymal stem cells: clinical trial update and perspectives[J]. J Orthop Translat, 2017, 9: 76-88. DOI: 10.1016/j.jot.2017.03.005.
|
| [6] |
Gersing AS, Schwaiger BJ, Nevitt MC, et al. Weight loss regimen in obese and overweight individuals is associated with reduced cartilage degeneration: 96-month data from the osteoarthritis initiative[J]. Osteoarthritis Cartilage, 2019, 27(6): 863-870.
|
| [7] |
Migliore A, Procopio S. Effectiveness and utility of hyaluronic acid in osteoarthritis[J]. Clin Cases Miner Bone Metab, 2015, 12(1): 31-33.
|
| [8] |
Merkely G, Ogura T, Ackermann J, et al. Clinical outcomes after revision of autologous chondrocyte implantation to osteochondral allograft transplantation for large chondral defects: a comparative matched-group analysis[J]. Cartilage, 2021, 12(2): 155-161.
|
| [9] |
Solheim E, Hegna J, Inderhaug E. Early determinants of long-term clinical outcome after cartilage repair surgery in the knee[J]. J Orthop, 2018, 15(1): 222-225.
|
| [10] |
Rodriguez-Merchan EC, Valentino LA. The role of gene therapy in cartilage repair[J]. Arch Bone Jt Surg, 2019, 7(2): 79-90.
|
| [11] |
Laupattarakasem W, Laopaiboon M, Laupattarakasem P, et al. Arthroscopic debridement for knee osteoarthritis[J/OL]. Cochrane Database Syst Rev, 2008(1): Cd005118. DOI: 10.1002/14651858.CD005118.pub2.
|
| [12] |
Scillia AJ, Aune KT, Andrachuk JS, et al. Return to play after chondroplasty of the knee in National Football League athletes[J]. Am J Sports Med, 2015, 43(3): 663-668.
|
| [13] |
Weiβenberger M, Heinz T, Boelch SP, et al. Is debridement beneficial for focal cartilage defects of the knee: data from the German Cartilage Registry (KnorpelRegister DGOU)[J]. Arch Orthop Trauma Surg, 2020, 140(3): 373-382.
|
| [14] |
Redondo ML, Beer AJ, Yanke AB. Cartilage restoration: microfracture and osteochondral autograft transplantation[J]. J Knee Surg, 2018, 31(3): 231-238.
|
| [15] |
Orth P, Gao L, Madry H. Microfracture for cartilage repair in the knee: a systematic review of the contemporary literature[J]. Knee Surg Sports Traumatol Arthrosc, 2020, 28(3): 670-706.
|
| [16] |
Mithoefer K, Mcadams T, Williams R J, et al. Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis[J]. Am J Sports Med, 2009, 37(10): 2053-2063.
|
| [17] |
Cole BJ, Farr J, Winalski CS, et al. Outcomes after a single-stage procedure for cell-based cartilage repair: a prospective clinical safety trial with 2-year follow-up[J]. Am J Sports Med, 2011, 39(6): 1170-1179.
|
| [18] |
Benthien JP, Behrens P. Reviewing subchondral cartilage surgery: considerations for standardised and outcome predictable cartilage remodelling: a technical note[J]. Int Orthop, 2013, 37(11): 2139-2145.
|
| [19] |
Zedde P, Cudoni S, Giachetti G, et al. Subchondral bone remodeling: comparing nanofracture with microfracture. An ovine in vivo study[J]. Joints, 2016, 4(2): 87-93.
|
| [20] |
袁林，郭燕庆，于洪波，等. 富血小板血浆治疗Ⅱ-Ⅲ期膝骨关节炎的疗效评价[J/CD]. 中华关节外科杂志(电子版), 2016, 10(04): 386-392.
|
| [21] |
Koh YG, Kwon OR, Kim YS, et al. Adipose-derived mesenchymal stem cells with microfracture versus microfracture alone: 2-year follow-up of a prospective randomized trial[J]. Arthroscopy, 2016, 32(1): 97-109.
|
| [22] |
Madry H, Gao L, Eichler H, et al. Bone marrow aspirate concentrate-enhanced marrow stimulation of chondral defects[J/OL]. Stem Cells Int, 2017, 2017: 1609685. DOI： 10.1155/2017/1609685.
|
| [23] |
Richter DL, Schenck RC, Jr., Wascher DC, et al. Knee articular cartilage repair and restoration techniques: a review of the literature[J]. Sports Health, 2016, 8(2): 153-160.
|
| [24] |
Gudas R, Gudaite A, Pocius A, et al. Ten-year follow-up of a prospective, randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint of athletes[J]. Am J Sports Med, 2012, 40(11): 2499-508.
|
| [25] |
Armiento AR, Stoddart MJ, Alini M, et al. Biomaterials for articular cartilage tissue engineering: learning from biology[J/OL]. Acta Biomater, 2018, 65: 1-20. DOI: 10.1016/j.actbio.2017.11.021.
|
| [26] |
Murphy RT, Pennock AT, Bugbee WD. Osteochondral allograft transplantation of the knee in the pediatric and adolescent population[J]. Am J Sports Med, 2014, 42(3): 635-640.
|
| [27] |
Gross A E, Shasha N, Aubin P. Long-term followup of the use of fresh osteochondral allografts for posttraumatic knee defects[J]. Clin Orthop Relat Res, 2005, (435): 79-87.
|
| [28] |
Moradi B, Schönit E, Nierhoff C, et al. First-generation autologous chondrocyte implantation in patients with cartilage defects of the knee: 7 to 14 years′ clinical and magnetic resonance imaging follow-up evaluation[J]. Arthroscopy, 2012, 28(12): 1851-1861.
|
| [29] |
Ebert JR, Edwards PK. The evolution of progressive postoperative weight bearing after autologous chondrocyte implantation in the tibiofemoral joint[J]. J Sport Rehabil, 2014, 23(3): 192-202.
|
| [30] |
Bonasia DE, Marmotti A, Rosso F, et al. Use of chondral fragments for one stage cartilage repair: a systematic review[J]. World J Orthop, 2015, 6(11): 1006-1011.
|
| [31] |
Bonasia DE, Martin JA, Marmotti A, et al. The use of autologous adult, allogenic juvenile, and combined juvenile-adult cartilage fragments for the repair of chondral defects[J]. Knee Surg Sports Traumatol Arthrosc, 2016, 24(12): 3988-3996.
|
| [32] |
Lee WS, Kim HJ, Kim KI, et al. Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: a phase IIb, randomized, placebo-controlled clinical trial[J]. Stem Cells Transl Med, 2019, 8(6): 504-511.
|
| [33] |
Huang BJ, Hu JC, Athanasiou A. Cell-based tissue engineering strategies used in the clinical repair of articular cartilage[J/OL]. Biomaterials, 2016, 98: 1-22. DOI： 10.1016/j.biomaterials.2016.04.018.
|
| [34] |
Temenoff JS, Mikos AG. Review: tissue engineering for regeneration of articular cartilage[J]. Biomaterials, 2000, 21(5): 431-440.
|
| [35] |
Churchman SM, Boxall SA, McGonagle D, et al. Predicting the remaining lifespan and cultivation-related loss of osteogenic capacity of bone marrow multipotential stromal cells applicable across a broad donor age range[J/OL]. Stem Cells Int, 2017：10. DOI: 10.1155/2017/6129596.6129596.
|
| [36] |
Yang J, Zhang YS, Yue K, et al. Cell-laden hydrogels for osteochondral and cartilage tissue engineering[J/OL]. Acta Biomater, 2017, 57: 1-25. DOI: 10.1016/j.actbio.2017.01.036.
|
| [37] |
Li S, Glynne-Jones P, Andriotis OG, et al. Application of an acoustofluidic perfusion bioreactor for cartilage tissue engineering[J]. Lab Chip, 2014, 14(23): 4475-4485.
|
| [38] |
Shi S, Chan AG, Mercer S, et al. Endogenous versus exogenous growth factor regulation of articular chondrocytes[J]. J Orthop Res, 2014, 32(1): 54-60.
|
| [39] |
Bellavia D, Veronesi F, Carina V, et al. Gene therapy for chondral and osteochondral regeneration: is the future now？[J]. Cell Mol Life Sci, 2018, 75(4): 649-667.
|
| [40] |
Grol MW, Lee BH. Gene therapy for repair and regeneration of bone and cartilage[J]. Curr Opin Pharmacol, 2018, 40: 59-66.
|
| [41] |
Evans CH, Ghivizzani SC, Robbins PD. Gene delivery to joints by intra-articular injection[J]. Hum Gene Ther, 2018, 29(1): 2-14.
|
| [42] |
Kim MK, Ha CW, In Y, et al. A multicenter, double-blind, phase III clinical trial to evaluate the efficacy and safety of a cell and gene therapy in knee osteoarthritis patients[J]. Hum Gene Ther Clin Dev, 2018, 29(1): 48-59.
|